BIO
Bio-Rad Laboratories, Inc.
$254.32
-1.17%
2026-05-08
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Key Fundamentals
P/E Ratio
42.85
Forward P/E
25.87
EPS (TTM)
$6.02
ROE
2.5%
Revenue Growth (YoY)
1.1%
Profit Margin
6.5%
Debt/Equity
20.12
Price/Book
1.01
Beta
1.06
Market Cap
$6.90B
Avg Volume (10D)
463K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$312.85
60D Low
$242.29
Avg Volume
264K
Latest Close
$254.32
Get breakout alerts for BIO
Sign up for Breakout Scanner to receive daily notifications when BIO triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Bio-Rad Laboratories, Inc. (BIO) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors BIO daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. BIO operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.